Scientists have developed a nasal spray that could do away with painful anaesthetic injections for dental procedures.
The spray, Kovacaine Mist, was as effective as standard anaesthetics in four out of five patients, according to researchers at the University of Buffalo.
The product has passed phase two clinical trials in the US, 'The Independent' reported.
Safety trials with the US Food and Drugs Administration could be complete by the end of the summer and final product approval in the US could be achieved by next year, according to the manufacturer, St Renatus LLC.
"This nasal spray could be a very promising addition to any dental practice," Carter said.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
